IP Library › Granted Patent US 11,617,833
Granted Patent B2
US 11,617,833 · App. 16/882,157 · Granted Apr 4, 2023

Self-contained auto-injector

Inventors: Robert F. Rioux (Ashland, MA); Matthew Laplaca (Franklin, MA); Brian Grasso (Wallingford, CT); Matt Bomes (Wellesley, MA)
Assignee: Falco Medical, LLC
A61M5/2033A61M5/1782A61M5/204A61M5/24A61M5/2466A61M5/3135A61M2005/206A61M2005/2013A61M2005/247A61M2005/3022
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,617,833
App. No.
16/882,157
Granted
Apr 4, 2023
Kind
B2
Abstract

A drug self-delivery device comprising a body portion containing a drug vial and a needle assembly, where the body portion is slidably engaged to a trigger portion. When engaged by a user pressing the trigger portion against the user's flesh, the needle assembly relative to the drug vial so as to align a needle port with an integral drug delivery port connected to the drug vial thereby allowing fluid flow of medication through the needle. Seals engaged by a penetration spring prevent loss of medication and prevent the need for direct connection between the needle assembly and the drug vial.

Claims (51)

1. A drug self-delivery device comprising:

a handheld portion having a proximal end, a distal end and a longitudinal axis therebetween;

a trigger portion in slidable engagement with the distal end of the handheld portion and defining an injection opening;

a drug vial disposed within the handheld portion, the drug vial containing a fluid medication;

a needle assembly comprising:

a needle having an interior lumen to allow the flow of medication;

a needle port for receiving medication from the drug vial;

an upper seal positioned toward the proximal end of the handheld portion relative to the needle port; and

a lower seal positioned toward the distal end of the handheld portion relative to the needle port; and

a drug delivery port configured to fluidly connect the drug vial to the needle port;

wherein the needle assembly has a first needle position in which the needle assembly is fully disposed within the handheld portion, and a second needle position where at least a portion of the needle extends through the injection opening; and

wherein the upper seal moves toward the lower seal as the needle assembly moves from the first needle position to the second needle position.

2. The drug self-delivery device of claim 1 further comprising a penetration spring configured to press the needle assembly from the first needle position to the second needle position when the trigger portion is slid toward the distal end of the handheld portion.

3. The drug self-delivery device of claim 1 wherein the needle port generally aligns with an exit of the drug delivery port when the needle assembly is in the second needle position.

4. The drug self-delivery device of claim 1 wherein the lower seal does not move relative to the trigger portion as the needle assembly moves from the first needle position and the second needle position.

5. The drug self-delivery device of claim 1 further comprising a separation strip configured to prevent the trigger portion from sliding toward the distal end of the handheld portion when the separation strip is disposed within a gap between the handheld portion and the trigger portion.

6. The drug self-delivery device of claim 5 further comprising a pull ring connected to a point along the separation strip wherein the pull ring is configured to remove the separation strip from the gap when pulled away from the handheld portion.

7. The drug self-delivery device of claim 6 wherein the handheld portion forms a concave outer surface shaped to fit against a user's appendage for transport such that the longitudinal axis of the handheld portion is generally parallel to the appendage.

8. The drug self-delivery device of claim 7 :

wherein the pull ring has a stored position in which it is sandwiched between the concave outer surface and the user's appendage and a deployed position where the pull ring swings away from the concave outer surface; and

wherein the pull ring transitions to the deployed position when the concave outer surface is separated from the user's appendage.

9. The drug self-delivery device of claim 5 wherein the separation strip comprises a non-conductive member extending into the handheld portion that separates the battery from an electrical contact until the separation strip is removed from the handheld portion.

10. The drug self-delivery device of claim 9 wherein when the separation strip is removed an electronic circuit is formed that is configured to send a signal to one or more external communication devices.

11. The drug self-delivery device of claim 9 further comprising a speaker, and wherein, when the separation strip is removed, an electronic circuit is formed that is configured to broadcast a pre-recorded instructional message via the speaker.

12. A method for administering medication stored within a drug self-delivery device comprising the steps of:

grasping a handheld portion of the drug self-delivery device having a proximal end, a distal end and a longitudinal axis therebetween and at least partially housing:

a drug vial containing a fluid medication to be administered;

a needle assembly comprising:

a needle with an interior lumen; and

a needle port for receiving medication from the drug vial; and

a drug delivery port configured to deliver medication from the drug vial to the needle assembly;

removing a separation strip that prevents the handheld portion from moving relative to a trigger portion of the drug self-delivery device;

placing the trigger portion adjacent to a user's skin at a location where the medication is to be administered, the trigger portion defining an injection opening; and

pressing the handheld portion toward the trigger portion such that a portion of the needle extends through the injection opening;

wherein removing the separation strip further removes a non-conductive member from between a battery and an electrical contact, thereby completing an electronic circuit.

13. The method of claim 12 wherein pressing the handheld portion toward the trigger portion causes the needle port to approximately align with the drug delivery port along a plane perpendicular to the longitudinal axis of the handheld portion.

14. The method of claim 12 wherein the electronic circuit is configured to send an alert signal to a remote communication device identifying that the separation strip has been removed.

15. The method of claim 12 wherein the electronic circuit is configured to broadcast a pre-recorded instructional message via a speaker housed within the handheld portion.

16. A drug self-delivery system comprising:

a handheld portion having a proximal end, a distal end and a longitudinal axis therebetween;

a trigger portion in slidable engagement with the distal end of the handheld portion and defining an injection opening;

a drug vial disposed within the handheld portion, the drug vial containing a fluid medication;

a needle assembly comprising a needle and a needle port, the needle assembly having a first position where the needle assembly is entirely disposed within the handheld portion and an extended position where the needle is at least partially extending through the injection opening;

a drug delivery port configured to deliver medication from the drug vial to the needle assembly when the needle assembly is in the extended position;

a battery;

an electronic contact; and

a non-conductive tooth positioned to separate the battery from the electronic contact.

17. The drug self-delivery system of claim 16 further comprising a separation strip connected to the non-conductive tooth and accessible from the exterior of the drug self-delivery system.

18. The drug self-delivery system of claim 17 wherein removal of the separation strip causes the battery to electrically couple with the electronic contact to activate an electronic circuit.

19. The drug self-delivery system of claim 18 further comprising a speaker, and wherein activation of the electronic circuit causes the speaker to broadcast a pre-recorded instructional message.

20. The drug self-delivery system of claim 18 , wherein activation of the electronic circuit is configured to send a wireless signal to a remote communication device indicating that the separation strip has been removed.

Assignments (2)
CERTIFICATE OF CONVERSION Recorded Jun 9, 2021
From: SUMMIT STREET MEDICAL LLC
To: SUMMIT STREET MEDICAL, INC.
Reel/Frame 056675/0737 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 28, 2021
From: SUMMIT STREET MEDICAL, INC.
To: FALCO MEDICAL, LLC
Reel/Frame 056381/0460 →
Continuity (5)
Continuation 15790263 · Oct 23, 2017
Provisional Application 62455241 · Feb 6, 2017
Provisional Application 62414871 · Oct 31, 2016
Related Publication 20220023540A1 · Jan 27, 2022
Related Publication 20220176041A2 · Jun 9, 2022
Cited By (5)
US 1,122,440 US 12,226,613 US 12,226,614 US 12,533,298 US 12,691,213